Finance

Beta
Lists
301017:SHE
ShuYu Civilian Pharmacy Corp Ltd
CNÂ¥14.38
-0.90%
(-0.13) 1D
Jun 3, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301017...
Open
CNÂ¥14.51
High
CNÂ¥14.70
Low
CNÂ¥14.15
Mkt. cap
5.90B
Avg. vol.
9.59M
Volume
7.79M
Dividend
0.31%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
57.92
52-wk high
CNÂ¥23.01
52-wk low
CNÂ¥10.52
EPS
CNÂ¥0.25
Shares outstanding
405.61M
No. of employees
16K
Open
CNÂ¥14.51
High
CNÂ¥14.70
Low
CNÂ¥14.15
Mkt. cap
5.90B
Avg. vol.
9.59M
Volume
7.79M
Dividend
0.31%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
57.92
52-wk high
CNÂ¥23.01
52-wk low
CNÂ¥10.52
EPS
CNÂ¥0.25
Shares outstanding
405.61M
No. of employees
16K
News stories
From sources across the web
About ShuYu Civilian Pharmacy Corp Ltd
CEO-
Employees15.9K
FoundedJan 21, 1999
Headquarters-
SectorDrug
Websiteshuyupingmin.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.50B
2.56B
2.88B
2.60B
Cost of goods sold
1.85B
1.91B
2.12B
1.93B
Cost of revenue
1.85B
1.91B
2.12B
1.93B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
611.18M
625.98M
685.33M
615.35M
Operating expense
607.79M
651.44M
678.62M
623.46M
Total operating expenses
2.46B
2.56B
2.79B
2.55B
Operating income
45.47M
5.17M
87.74M
51.31M
Other non operating income
-10.57M
-8.69M
-14.61M
-8.63M
EBT including unusual items
13.08M
92.69M
36.15M
12.65M
EBT excluding unusual items
7.22M
-35.05M
45.71M
11.47M
Income tax expense
4.80M
22.36M
20.10M
3.40M
Effective tax rate
36.73%
24.12%
55.59%
26.84%
Other operating expenses
5.73M
158.91K
10.09M
2.87M
Net income
10.63M
72.90M
5.09M
10.36M
Net profit margin
0.42%
2.84%
0.18%
0.40%
Earnings per share
-
-
-
-
Interest and investment income
4.47M
864.67K
2.54M
3.46M
Interest expense
-32.48M
-32.39M
-29.97M
-34.67M
Net interest expenses
-28.01M
-31.53M
-27.44M
-31.21M
Depreciation and amortization charges
-
-
-
-
EBITDA
60.28M
22.05M
100.61M
64.17M
Gain or loss from assets sale
-9.03M
9.03M
-27.07M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer